Osteopontin: a biomarker to predict the outcome of inflammatory heart disease

Karin Klingel1, Reinhard Kandolf

  • 1Department of Molecular Pathology, University Hospital Tübingen, Tübingen, Germany. karin.klingel@med.uni-tuebingen.de

Insights

Osteopontin (OPN) is crucial in heart inflammation and fibrosis. Elevated OPN in macrophages signals active cardiac inflammation, potentially serving as a biomarker for myocarditis before heart damage occurs.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Virus-induced myocarditis can lead to chronic inflammation, disrupting the heart's matrix and causing dysfunction.
  • Cardiomyocyte death triggers immune responses involving macrophages and T cells, with cytokines like IL-10 and TGF-β regulating inflammation.
  • Osteopontin (OPN), a matricellular protein, plays a role in inflammatory pathways and cardiac repair.

Purpose of the Study:

  • To investigate the role of osteopontin (OPN) in viral myocarditis, specifically its impact on fibrosis and cardiac remodeling.
  • To determine if OPN expression in macrophages can serve as a biomarker for active cardiac inflammation.

Main Methods:

  • Utilized a coxsackievirus B3-induced myocarditis mouse model.
  • Analyzed OPN expression in macrophages in both the animal model and human patient samples (acute/chronic myocarditis, dilated cardiomyopathy).

Main Results:

  • Early OPN expression in macrophages was identified as a key factor in fibrosis and cardiac remodeling in the model.
  • OPN did not affect the antiviral immune response efficacy.
  • High OPN expression in macrophages was observed in patients with acute and chronic myocarditis, but not in end-stage dilated cardiomyopathy.

Conclusions:

  • Cardiac OPN expression, particularly in macrophages, is linked to ongoing inflammation in myocarditis.
  • OPN may serve as a valuable biomarker for detecting cardiac inflammation preceding fibrosis and adverse cardiac remodeling.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...